Getting prior authorization for medications can be a struggle in allergy and asthma care, but creating templates and paying ...

Novartis says that around a third of patients with asthma have symptoms that can’t be controlled using LABA/ICS dual therapy such as GSK’s older drug Seretide – which dominated the market ...

在3月21~3月22日召开的“2025呼吸健康与气道疾病国际论坛”上，中外指南对于“重度哮喘”的定义、诊断、分型、治疗药物、“临床治愈”等方面的最新推荐以及对应的异同点成为会议讨论焦点。

Asthma is an airway inflammatory disease characterized ... Inhaled corticosteroids; LABA: Long-acting β 2-agonists; PEF: Peak expiratory flow; Pre-BD: Value measured prebronchodilator; PY ...

In this article, we'll explore what a rescue inhaler is and the signs that indicate you may need one. A rescue inhaler, also known as a bronchodilator or short-acting beta-agonist, is a medical device ...

for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp Digihaler – which delivers inhaled corticosteroid budesonide and long-acting beta agonist formoterol ...

Mar. 12, 2025 — A lung function test used to help diagnose asthma works better in the morning, becoming less reliable throughout the day, researchers have found. Using real world data from 1,600 ...

哮喘患病率攀升，全程管理策略升级，生物制剂助力突破传统治疗局限，精准控制病情，守护患者呼吸健康。支气管哮喘（简称哮喘）是一种常见的慢性炎症性呼吸道疾病，影响着全球数以亿计的人口。据世界卫生组织（WHO）统计，哮喘的全球患病率不断上升，已成为全球范围内的重大公共卫生问题[1]。哮喘不仅给患者带来了身体上的痛 ...

近年来，哮喘与慢性阻塞性肺疾病稳稳地占据了慢性气道疾病领域的两大主导地位。全球哮喘负担形势严峻。2021年，全球哮喘患者约2.6亿，死亡病例约43.6万例。我国20岁及以上人群哮喘患病率为4.2%，约4570万哮喘患者。自2010年后，我国青少年和成 ...

Ravijyot Saggu offers an expert summary of the recent child deaths related to asthma and allergies report and necessary ...

Nucala is a prescription drug that’s used to treat eosinophilic asthma in adults and some children and for other conditions. The active ingredient in Nucala is mepolizumab. (An active ingredient ...